Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer
Clinical trial NCT01457131 · TERMINATED
Trial details
- NCT number
- NCT01457131
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-06
- Primary completion
- 2013-08-07
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.